Sakar Healthcare Limited
NSE:SAKAR.NS
Overview | Financials
Company Name | Sakar Healthcare Limited |
Symbol | SAKAR.NS |
Currency | INR |
Price | 309 |
Market Cap | 6,720,719,100 |
Dividend Yield | 0% |
52-week-range | 295.15 - 479 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sanjay Surendra Shah |
Website | https://www.sakarhealthcare.com |
An error occurred while fetching data.
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD